Next Article in Journal
Using Multiple Approaches in Docking Pose Evaluation – Application to the GABAA Receptor
Previous Article in Journal
Pluronic® F-68 Enhances the Nanoparticle-Cell Interaction
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessAbstract
Sci. Pharm. 2009, 77(Short Lectures (SL)), 180; (registering DOI)

Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin

Department of Pharmacognosy, University Vienna, Althanstraße 14, 1090, Vienna, Austria
Author to whom correspondence should be addressed.
Received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
PDF [195 KB, uploaded 11 May 2017]


Histone deacetylase inhibitors (HDACi) have received high interest as anti-cancer agents recently. HDACi may influence tumor growth by an inhibition of angiogenesis as well as by increasing tumor cell immunogenicity [1]. In many clinical trials the effect of several HDACi on different tumors are studied at the moment [2].
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

KRASTEVA, S.M.; KRENN, L. Validation of Fluorimetric Assay of Histone Deacetylase for Inhibitors from Plant Origin. Sci. Pharm. 2009, 77, 180.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top